author-photo

Isabelle Miconnet

Ludwig Institute for Cancer Research

32

Papers

1537

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection

2011 Blood
Show All
- Source
- Cite
- Save
Citations (250)
Large TCR Diversity of Virus-Specific CD8 T Cells Provides the Mechanistic Basis for Massive TCR Renewal after Antigen Exposure

2011 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (44)
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.

2006 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (55)
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity

2006 Vaccine
Show All
- Source
- Cite
- Save
Citations (13)
Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies: A Phase I clinical study

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression

2005 Biochemical Journal
Show All
- Source
- Cite
- Save
Citations (76)
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes

2004 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (49)
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy

2004 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (125)
EphA2 as Target of Anticancer Immunotherapy Identification of HLA-A*0201-Restricted Epitopes

2003 Cancer Research
Show All
- Source
- Cite
- Save
Citations (51)
Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction

2001 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (49)